Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07521722 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

DIV-AD BARCELONA: Alzheimer's Blood-Based Biomakers for a Diverse Community

Study acronym: DIV-AD
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The DIV-AD study aims to find out whether levels of Alzheimer's disease markers in blood differ among the main ethnical groups living in central Barcelona. It will also examine how factors such as age, income, education, and health conditions may affect these levels. In addition, the study will identify barriers that may make it difficult to use these blood tests in primary care. The final goal is to help ensure that everyone in Barcelona has fair access to early prevention strategies for Alzheimer's disease.
Trial Details
NCT Number NCT07521722
Lead Sponsor Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
Collaborators: Universitat Pompeu Fabra, Hospital del Mar Research Institute (IMIM), Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina, Hospital del Mar
Conditions
(from sponsor)		 Alzheimer Disease, Cognitive Dysfunction, Cognitive Disorder, Dementia, Neurodegenerative Disease
Related terms Alzheimer Disease, Charcot-Marie-Tooth disease, Type 1F, Cognitive Dysfunction, Dementia, Neurodegenerative Diseases, Plaque, Amyloid
Enrollment 250 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov